Fiala

Peptide library › Bone health

Etelcalcetide

Also known as Parsabiv

FDA-approved drugBone health

Injection given at dialysis to lower overactive parathyroid hormone in people with kidney failure.

What people use it for

What Etelcalcetide does in the body

A calcimimetic: it makes the parathyroid glands' calcium sensors more sensitive, so they release less parathyroid hormone. This protects bones and blood vessels in kidney failure.

Strength of evidence

Strong: Phase 3 trials lowered parathyroid hormone more than placebo and the tablet cinacalcet.

Look up the evidence

Live searches of official databases. New to the terms? See the glossary.

Reported side effects & risks

Who should avoid it or take extra care

Not a complete list. Check with a doctor or pharmacist about your own health and medicines.

Regulatory status

FDA-approved in 2017. Given in dialysis units.

How it's taken

Route: Injection into the dialysis line at the end of each session, three times a week

How long it lasts (half-life): About 3 to 5 days in people on dialysis

Storage

Stored and prepared by the pharmacy or clinic, following the product label.

Latest research & news

Picked automatically from PubMed, ClinicalTrials.gov and the FDA, and updated daily. Early, lab and animal studies often don't carry over to people.

Keep track of Etelcalcetide privately

Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.

Open Etelcalcetide in Fiala How to install
Not medical advice. This page is general education. Talk to a qualified clinician before starting, stopping or changing any treatment.

More in Bone health